ARCHIVES

Drug Development: FDA Grants Breakthrough Therapy Designation to CTL019 In ALL

This article is from The Cancer Letter archive.

Vol. 40 No. 28 | July 11, 2014

Download PDF Visit The Full Archive

Related Articles

PDX Shows 27% Response In T-Cell Lymphoma In Study

December 26, 2008

Senate Markup Would Give NCI $985 Million, Offers Prospect That Reductions In Grants Will Be Restored

December 10, 1982

New Food Services Contractor Takes Over NIH Cafeterias.

July 14, 2000

In Brief: Benacerraf, Snell, Dausset Win Nobel Prize; AACE Seeks Increase In Clinical Education Funds

October 17, 1980

Cancer Prevention Fellowship Program Offers Enhancement

March 8, 1991

Amgen Cancels Rilotumumab Trials in Gastric Cancer

December 26, 2014